ODDB.org: Open Drug Database

Xolair 75 mg/0.5 ml, Injektionslösung in einer Fertigspritze -

Swissmedic Key	68030004	Registration Holder	Novartis Pharma Schweiz AG
Name	Xolair 75 mg/0.5 ml, Injektionslösung in einer Fertigspritze	Date of registration	08.04.2021
		Introduction of Sequence	08.04.2021
ATC-Classification	Omalizumab (R03DX05)	Revision date
WHO	WHO-DDD	Valid until	07.04.2026
Index Therapeuticus (BSV)	03.04.50.	Show package size
Index Therapeuticus (Swissmedic)	03.04.50.	Description
Swissmedic categorie.	B
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	187.92	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	220.80
Feedback	FB	Daily cost
GTIN	7680680300046	Medication Code	Biotechnologika
Pharmacode		Disponibility

Composition

omalizumabum 75.00 mg, arginini hydrochloridum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.50 ml.

Packungsbestandteile

Galenic Form

Injection solution in prefilled syringe

Excipiens

Active Agent	Dose
Omalizumab	75mg / 0.5ml

BAG: Active Agent	Dose
Omalizumab	75 mg

Inactive agents
Arginine Hydrochloride
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 20

Source

Data was imported : 07.08.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH